XML 19 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF CHANGES IN TOTAL EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common Shares
Capital in Excess of Stated Value
Accumulated Other Comprehensive Loss
Retained Earnings
Non- controlling Interests
Beginning Balance at Dec. 31, 2020 $ 1,910,528 $ 7,175 $ 314,056 $ (756,842) $ 2,335,216 $ 10,923
Beginning Balance (in shares) at Dec. 31, 2020   100,447        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) (82,711)       (85,477) 2,766
Other comprehensive income/(loss):            
Translation loss (75,636)     (75,052)   (584)
Defined benefit plan adjustment [1] 471,350     471,350    
Derivative financial instruments [1] 1,119     1,119    
Other comprehensive income/(loss) 396,833     397,417   (584)
Dividends paid to noncontrolling interest (1,009)         (1,009)
Dividends (179,734)       (179,734)  
Issuance of stock awards 1,111   1,111      
Issuance of stock awards (in shares)   309        
Shares repurchased (218,085)   (218,085)      
Stock repurchased and retired (in shares)   (3,386)        
Share-based compensation 22,608   22,608      
Ending Balance at Dec. 31, 2021 1,849,541 $ 7,175 119,690 (359,425) 2,070,005 12,096
Ending Balance (in shares) at Dec. 31, 2021   97,370        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) 466,980       466,437 543
Other comprehensive income/(loss):            
Translation loss (68,780)     (69,240)   460
Defined benefit plan adjustment [1] 424     424    
Derivative financial instruments [1] (1,842)     (1,842)    
Other comprehensive income/(loss) (70,198)     (70,658)   460
Purchase of noncontrolling interest (13,196)   7,080     6,116
Dividends (188,259)       (188,259)  
Issuance of stock awards 1,167   1,167      
Issuance of stock awards (in shares)   354        
Shares repurchased (4,547)   (4,547)      
Stock repurchased and retired (in shares)   (79)        
Share-based compensation 31,309   31,309      
Ending Balance at Dec. 31, 2022 $ 2,072,797 $ 7,175 140,539 (430,083) 2,348,183 6,983
Ending Balance (in shares) at Dec. 31, 2022 97,645 97,645        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income (loss) $ 475,901       474,959 942
Other comprehensive income/(loss):            
Translation loss 70,308     70,738   (430)
Defined benefit plan adjustment [1] (8,654)     (8,654)    
Derivative financial instruments [1] 1,737     1,737    
Other comprehensive income/(loss) 63,391     63,821   (430)
Dividends (198,762)       (198,762)  
Issuance of stock awards 1,345   1,345      
Issuance of stock awards (in shares)   488        
Shares repurchased (10,617)   (10,617)      
Stock repurchased and retired (in shares)   (176)        
Share-based compensation 27,780   27,780      
Ending Balance at Dec. 31, 2023 $ 2,431,835 $ 7,175 $ 159,047 $ (366,262) $ 2,624,380 $ 7,495
Ending Balance (in shares) at Dec. 31, 2023 97,957 97,957        
[1] net of tax